Introduction
Globally, ischaemic heart disease (IHD) is the most common reason for burden of disease and preterm mortality. 1 Due to the strong effect of IHD on work disability, sickness absence (i.e. temporary work disability) is almost always prescribed as a rehabilitation measure in health care services for individuals with IHD. 2 A considerable proportion of these individuals are at risk of permanent work IHD as well as extended working lives, there is a need of scientific knowledge on prognostic factors for preterm labour market exit in individuals with IHD. Still, to date related scientific knowledge is sparse. [2] [3] [4] [5] [6] Among these prognostic factors, comorbid disorders, particularly common mental disorders, CMDs, i.e. depressive and anxiety disorders, are of clinical importance. 7 A bidirectional relationship between IHD and CMD has been reported and several shared pathological processes have been proposed. 8, 9 These range from pathophysiological (genetic predisposition, dysfunction of the autonomic nervous system or hypothalamic-pituitary-adrenal axis, inflammation, and endothelial dysfunction) to behavioural (adherence, obesity, smoking, sedentary lifestyle) and psychological (stress response, effects of long standing disease) mechanisms. While comorbidity with a depressive disorder has been shown to worsen the prognosis of IHD in terms of mortality, 10 there is to date no scientific information on the effect of a comorbid CMD on the risk of preterm labour market exit related to IHD. Moreover, knowledge on a potential synergistic effect of IHD and CMDs with regard to a subsequent risk of DP is lacking to date. Such studies should ideally consider to which extent differences in socio-demographic characteristics and other somatic comorbidity effect a potential synergistic effect of IHD and CMD with later DP. 3 Moreover, due to the considerable sex differences in IHD, CMD and work disability, related studies are best stratified for sex. 11, 12 The aim of this study was to investigate the separate and joint effect of IHD and CMD on the risk of DP for women and men of working age, adjusting for socio-demographic and morbidity factors. 
Material and methods

Register data
With the help of the de-identified personal identification number, a unique 10-digit number assigned to all Swedish residents, the following 5 registers were linked: (i) Longitudinal Integration Database for Health Insurance and Labour Market Studies (LISA database) held by Statistics Sweden: sex, age, family situation, education, country of birth, and type of living area measured at the end of 2004 and emigration in 2005-10. The cohort was also identified with the help of this database; (ii) MicroData for Analysis of the Social Insurance database (MiDAS) held by the Social Insurance Agency: sickness absence in 2005 (date, main diagnoses) and DP (date 2004-10); (iii) national patient register: morbidity (date and diagnoses of in-and specialized outpatient care, 2000-05); (iv) causes of death register: mortality (date, 2005-10) , and (v) the prescribed drug register: type of prescribed, purchased medication (July-December 2005). Registers 3, 4, and 5 were derived from the Swedish National Board of Health and Welfare. Type of prescribed medication was identified by the respective code in the anatomical therapeutic chemical classification system (ATC code). Diagnoses were coded following the international classification of diseases (ICD) version 10.
The sickness insurance system in Sweden
In Sweden, all adults in working age receiving income from work or unemployment benefits can be granted sickness benefits, if their work capacity is decreased due to disease or injury. 10 All adults 30-64 years of age living in Sweden with permanent work disability due to disease or injury can be granted DP. Individuals 19-29 years of age can be granted DP due to temporary work disability or in order to complete compulsory education.
Exposure
Identification of IHD and CMDs was through diagnosis-specific data on sickness absence (main diagnosis) and in-or specialized outpatient care (main or side diagnosis) in 2005. The following ICD10 codes were used to define IHD: I20-I25 and CMD: F30-F39 'mood disorders' and F40-F48 'neurotic, stress-related and somatoform disorders'. Prescription of antidepressant medication (ATC code N06A) in the year 2005 was additionally used to define CMDs.
Measurement of outcome
Being granted all-cause DP (including both part-time and full-time) was measured from January 2006 up to December 2010.
Covariates
Baseline socio-demographic characteristics comprised sex, age, country of birth, level of education, type of living area and family situation at December 2004. 
Statistical analyses
With the help of Cox proportional hazard regression models, hazard ratios (HR) and 95% confidence intervals (CI) for the exposure variables (IHD and CMDs, respectively) with regard to the outcome variable (all-cause DP) were estimated. Reference groups were individuals without any sickness absence/specialized health care due to IHD and those without any sickness absence/specialized health care due to CMDs/antidepressant prescription, respectively. model IV, we added data on cardiovascular morbidity in the analyses with CMDs as the exposure of interest. In case of IHD as the exposure variable, additional adjustment in model IV was due to mental morbidity.
Measures of interaction on an additive scale
Additive interactions between co-occurrence of IHD and CMDs in 2005 in relation to subsequent DP are expressed as synergy indices (S). This was calculated applying following equation: S = HR IHD and CMDs -1/([HR no IHD but CMDs -1] þ [HR no CMDs but IHD -1]), as deviation from an additive. [11] [12] [13] [14] Thus, the synergy index equals the ratio of the observed effect with combined exposure to both risk factors in relation to the effect to be expected when independently acting causes operate jointly. S would then equal 1 for causes acting independently (no interaction or exact additivity), S would be greater than 1 in case of positive interaction or more than additivity, and S would be lower than 1 in case of negative interaction or less than additivity (factors neutralizing each other). S can range between 0 and 1.
14 In addition to the crude model, the analyses related to S are adjusted for age, education, family situation, country of birth, and type of living area in model I. In the final model II, further adjustment was due to somatic morbidity other than cardiovascular diagnoses. Moreover, we calculated relative excess risk due to interaction (RERI) as a metric of departure from additive effects by the equation: RERI = HR IHD and CMDs -HR no CMDs but IHD -HR no IHD but CMDs þ 1. [13] [14] [15] [16] Moreover, the attributable proportions (AP) due to interaction were computed using the equation: AP = RERI/HR IHD and CMDs . This equals the proportion of DP that would theoretically be prevented if the interaction of the two exposures could be eliminated. With regard to the existence of an interaction effect, RERI and AP can be interpreted similarly to the interpretation of S. While RERI can range from À1 to þ1, AP goes from -1 to þ1. 95% Confidence intervals for S, RERI, and AP were computed as previously suggested.
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The study was approved by the Regional Ethical Review Board of Stockholm.
Results
Out of the total of 4 823 069 individuals, 13 621 persons (0.1% of women and 0.4% of men) were affected by IHD in 2005 (specialized health care or sickness absence due to IHD). The overwhelming proportion of IHD individuals (74%) was identified through specialized outpatient care visits. In comparison, 252 244 individuals (7.1% of women and 3.6% of men) were affected by CMDs in the year 2005 (sickness absence, specialized health care, or prescription of antidepressants). The majority of individuals were identified through prescription of antidepressants (78%). From the individuals with IHD, 9.2% (14.3% of women and 7.8% of men) were also suffering from a CMD. From the individuals with CMDs, 0.5% (0.3% of women and 0.9% of men) had also IHD during the same time period. Differences in socio-demographic characteristics in individuals with IHD, CMDs, both, or none of them are presented in Table 1 .
Men were affected more than three times more often by IHD than women. Women, however, were affected by CMDs almost twice as often as men. The majority of individuals with IHD were in the highest age group (55-64 years). Individuals with IHD more often had a lower educational level and were married/living with partner without children than individuals with CMDs or individuals without any of these disorders. Individuals with CMDs, however, were more often single/divorced/separated/widowed with children than individuals with IHD or subjects without any of the two disorders.
In total, 81 994 individuals (1.9% of women and 1.5% of men) were granted DP between 2006 and 2010. This compares to 13.1 and 10.2% of women and men with IHD being granted DP during followup and 8.3 and 8.7% of women and men with CMDs, respectively. The proportion of women and men with both IHD and CMDs in 2005 who were granted DP in the follow-up period was 21.1 and 24.8%, respectively.
In Table 2 , HRs for DP in women and men with IHD or CMDs in 2005 are shown. In the crude models, IHD was associated with a slightly higher HR for DP compared to CMDs. Adjustment for age (model I) had a stronger effect on HRs in relation to IHD than CMDs. Further adjustment for socio-demographic and morbidity measures lowered the estimates only to some extent. Regarding IHD, HRs for DP were similar in women and men, while HRs for DP in individuals with CMDs were slightly higher in men compared to women, in all models.
In Table 3 , the synergistic effects between IHD and CMDs regarding the hazard for DP are presented. In the crude models, HR for DP in those who were affected by both disorders were higher than the sum of HRs related to either disorder (IHD or CMDs). This resulted in significant synergy indices exceeding 1 in both sexes, somewhat higher in men. After adjustment for socio-demographic variables (model I) the synergistic effect in men was considerably lowered; in women the effect was lost. Adjusting for co-morbidity (model II) further lowered the synergistic effect, which resulted in a loss of significance also in men ( Table 3) . Similar effects in the adjustment steps were seen for the relative excess risks due to interaction (RERI) and the attributable proportions due to interaction (AP). In women, RERI decreased from 3.51 in the crude model to -0.90 in the adjusted model. The respective decrease in men was from 10.83 to 0.94.
Discussion Main findings
In this large, population-based, prospective cohort study including all individuals of working ages in Sweden, we found a three-fold higher risk of future DP in women and men with a diagnosis of IHD compared to individuals without IHD, after adjustment for various sociodemographic and morbidity measures. Estimates for subsequent DP in relation to CMDs were five-fold and six-fold for women and men, respectively. Ischaemic heart disease and CMDs had a synergistic effect with regard to a future risk of DP in men but not in women, when adjusted for socio-demographic factors. When additionally adjusting for somatic co-morbidity (other than cardiovascular morbidity) this synergy effect did not reach statistical significance in men either. indicate higher risk estimates for subsequent DP in case of CMDs compared to IHDs. This is in line with previous findings using more comprehensive diagnostic categories. 17 Different explanations might underlie these results. Individuals with CMDs might seek help within the health care setting relatively late in the development of the disease, partly due to the underlying stigma, which is still related to mental disorders. 18 Individuals might then primarily seek help within primary health care settings, where adequate diagnostics and treatment of CMDs might potentially be suboptimal. 19, 20 It should be kept in mind that adjustment for age considerably decreased the estimates for subsequent DP in case of IHD, but only marginally in case of CMDs. In general, the HRs for DP associated with IHDs were equal for women and men, while risk estimates for DP in relation to CMDs were somewhat higher in men than in women. This should be discussed in the light of the known higher prevalence of CMDs in women. 21 In men, CMDs might be more often under-or misdiagnosed and therefore often not optimally treated. 22 Men with CMDs are also reported to have a different health care seeking behaviour than women and CMDs, particularly depression, in men might be characterized by different clinical manifestations. 22 Therefore, we can assume that symptoms are more severe, when CMDs are diagnosed in men, and this might explain the higher risk for DP related to CMDs in men compared to women. Still, when comparing estimates in women and men, it should be kept in mind that HRs are derived from sex-stratified analyses.
Findings from previous studies suggest an adverse effect of a comorbid CMD on return to work in individuals with IHD. 4, 7 We could now also show that a co-morbid CMD increases the risk of preterm labour market exit (DP) following IHD in both women and men. Possible explanations for the adverse effect of CMDs on the risk of DP in individuals with IHD might not only include a direct effect on reducing work ability, but also indirect effects on decreasing the likelihood of adherence to treatment, participating in rehabilitations programs and making potentially necessary lifestyle changes after an IHD event. We also found a synergy effect between IHD and CMD with regard to subsequent granting of DP in both sexes, in the crude analyses. This effect was lost when adjusting for age and other sociodemographic characteristics in women and when additionally adjusting for other co-morbid somatic disorders in men. With regard to IHD, women are reported to get the disease in general several years later than men, which entails a higher risk for comorbid diseases and work disability. 11, 12 A number of somatic disorders including diabetes mellitus, are known to be comorbid with IHD and have been reported to have a deleterious effect on work ability. 23 Processes leading to DP in individuals with IHD seem to be multifactorial and may involve the presence of CMD as well as comorbidity with other somatic diseases. Common mental disorders are often characterized by an early age of onset, recurring episodes and emerging co-morbid conditions and might contribute differentially to the ethiology of IHD, which typically ...................  ............................................................................................................................................................................................................... ..... has a much later onset. 24 Therefore, future studies on the CMD-IHD link are advised to apply a life-course perspective in order to disentangle the complexity of these temporal relations. 25 Here, individuals with a CMD may be trapped in a self-perpetuating cycle involving stressful life circumstances, adverse health behaviour, low help-seeking behaviour, emergent somatic co-morbidity and long periods of work disability. 25 Cumulative disadvantages related to CMDs over the life course may take a long-term toll on cardiovascular health and worsen functional and occupational outcome. On the other hand, it is also possible that an IHD event triggers the emergence of CMD symptoms, which may aggravate the disabling process leading to granted DP.
Strengths and limitations
The prospective cohort design, the population-based and very large cohort (> 4.8 million) with annual and detailed data for all individuals at risk of DP, the long follow up (5 years), and practically no drop-out rates are the main strengths of this study. Another strength is the high quality of data in the used administrative registers. could be identified by using several different registers, e.g. both regarding sickness absence, in-and specialized outpatient care, and prescribed medication. Moreover, diagnoses related to the exposure have been set by physicians, i.e. they were not self-reported. Exposure, covariates and outcome measures were recorded independently from each other. The whole population of working age in Sweden was included and offered satisfactory statistical power for the sex-stratified analyses, including a wide range of possible confounders as well as for diagnoses at detailed level.
As a limitation, the fact that the register on prescribed medication only holds data from July to December 2005 should be mentioned. Therefore, we did not have information regarding previous medication. In this study, antidepressant prescription was-among diagnosis-specific measures-used to define individuals with CMD. It should be noted that antidepressants can be prescribed in case of musculoskeletal and neuropathic pain. Still, the literature regarding the treatment of musculoskeletal pain without any symptoms of CMDs is inconclusive. 28 With regard to neuropathic pain, predominantly treatment with tricyclic antidepressants (TCAs) is recommended. 28 As TCAs represent a small fraction of prescribed antidepressants, 29 it is unlikely that our findings were mainly driven by this type of medication. Additionally, knowledge about the validity of the sickness absence diagnoses is limited, although one study published on this reported an acceptable validity. 30 Regarding sickness absence, we only had access to the main diagnosis, therefore some residual confounding due to comorbidity or unmeasured disease might have occurred. Several additional factors might add to an increased risk of DP and might potentially confound the associations of CMD and/or IHD with subsequent DP. These factors include certain disease-and work-related factors as well as factors related to the health care system and health behaviour. 31 Unfortunately, information on these variables was not available in the database used for this study.
Conclusions
Our results indicate that a comorbid CMD worsens the prognosis of IHD in terms of early exit from the labour market for both women and men of working ages. Besides the effect of a CMD, mechanisms to an adverse occupational outcome following IHD seem to include a strong effect of age and other socio-demographic characteristics (particularly in women) and of other comorbid somatic disorders (in both sexes). Thus, processes that lead to early exit from the labour market in individuals with IHD are likely to be multifactorial and might involve the presence of a CMD as well as comorbidity with other somatic diseases. It is crucial to give attention to CMDs and other comorbid disorders among individuals presenting with IHD, in order to achieve better outcomes and avoid loss of productivity and permanent exit from the labour market, in terms of DP.
